Pancreas.org logo
Patients Physicians Research

Home
PATIENTS
Acute pancreatitis
Chronic pancreatitis
Hereditary pancreatitis
HPRN Newsletter
HP Genetic Testing
Pancreatic cancer
Pancreas Test
Treatment / Pain Other patient resources
Genetic testing

Advocacy groups
Support groups
MERCK Manual Referral to UPMC
Other pancreas centers
PHYSICIANS
Disease information
Genetic testing
Clinical Trials
Clinical Trials
CME programs
Products
Referrals
SCIENTISTS
Genetic research
Research Groups
MMPSG
EUROPAC
RESOURCES & LINKS
Research Foundations
National Pancreas Foundation
PanCAN
Lustgarten
The Cystic Fibrosis Foundation
Other links

Patients > Hereditary Pancreatitis

Hereditary Pancreatitis Research Newsletters

OMIM Entry on Hereditary Pancreatitis

OMIM Entry on SPINK1 Mutations

What Is Hereditary Pancreatitis?

Hereditary Pancreatitis (HP) is a rare genetic condition characterized by recurrent episodes of pancreatic attacks, which can progress to chronic pancreatitis. Symptoms include abdominal pain, nausea, and vomiting. Onset of attacks typically occurs between within the first two decades of life, but can begin at any age. In the United States, it is estimated that at least 1,000 individuals are affected with hereditary pancreatitis.

HP has also been linked to an increased lifetime risk of pancreatic cancer. Pancreatic cancer is the 4th most leading cause of cancer deaths among Americans. Individuals with hereditary pancreatitis appear to have a 40% lifetime risk to develop pancreatic cancer. This increased risk is heavily dependent upon the duration of chronic pancreatitis and environmental exposures to alcohol and smoking. One recent study suggested that individuals with chronic pancreatitis for more than 25 years had a higher rate of pancreatic cancer when compared to individuals in the general population. This increased rate appears to be due to the prolonged chronic pancreatitis rather than having a gene mutation (all cationic trypsinogen mutations). It is important to note that these risk values may be higher than expected because these studies on pancreatic cancer use a highly selective population rather than a randomly selected population.

MMPSG

Trypsin

HP Overview

 
 

DISCLAIMER: This information is designed as a tool for background for pancreatic disorders and is not designed to serve as sole medical advice or meant to replace a full medical evaluation. Please consult your personal physician for additional information before making any changes to your diet, lifestyle, or medical treatment.

Updated March 28, 2005

Contact Dr. Whitcomb for questions or comments about this site.
Copyright © 2000 Cybergene Diagnostics. All Rights Reserved.

Designed & developed by UnlimitedFOCUS

University of Pittsburgh GI Bulletin Board